This article is more than 5 years old. Information may no longer be current.

VIDEO: Antithrombotic therapy strategies in diabetes 'rapidly evolving'

ByDeepak L. Bhatt, MD, MPH

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

PHILADELPHIA — In this video exclusive, Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Heart and Vascular Center and professor of medicine at Harvard Medical School, provides insights on the use of antithrombotic therapy in patients with diabetes.

Antithrombotic therapy in patients with diabetes has been “rapidly evolving” over the past few years, Bhatt, Cardiology Today’s Intervention Chief Medical Editor and Cardiology Today Editorial Board Member, said here.

Bhatt highlights updates in use of aspirin, duration of dual antiplatelet therapy and new data that show beneficial effects of aspirin plus a low-dose novel oral anticoagulant in patients with diabetes.

Watch the video for more.